KT

KHAN Technology Transfer Fund

Europe, Nordrhein-Westfalen, Germany, Dortmund

Description

KHAN Technology Transfer Fund operates as an investment firm.

Investor Profile

KHAN Technology Transfer Fund has made 4 investments, with 0 in the past 12 months and 75% as lead.

Stage Focus

  • Seed (75%)
  • Series A (25%)

Country Focus

  • Czech Republic (50%)
  • United Kingdom (25%)
  • Germany (25%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Biotechnology
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does KHAN Technology Transfer Fund frequently co-invest with?

IP
Europe, Hlavni mesto Praha, Czech Republic, Praha
Co-Investments: 1
Cumulus Oncology
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
SV Investment Corp
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Co-Investments: 1
Co-Investments: 1
i&i Biotech Fund
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 2

What are some of recent deals done by KHAN Technology Transfer Fund?

Casinvent Pharma

Brno, Jihomoravsky kraj, Czech Republic

Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.

MedicalPharmaceutical
SeedJan 31, 2024
Amount Raised: $1,728,713
Nodus Oncology

Snodland, Kent, United Kingdom

Nodus Oncology Developing the DDR targeting therapies.

BiotechnologyOncology
SeedFeb 7, 2023
Amount Raised: $2,892,995
Casinvent Pharma

Brno, Jihomoravsky kraj, Czech Republic

Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.

MedicalPharmaceutical
SeedSep 26, 2022
Amount Raised: $1,250,607
Qli5 Therapeutics

Dortmund, Nordrhein-Westfalen, Germany

Qli5 Therapeutics develops a new class of proteasome inhibitors.

MedicalTherapeutics
Series ADec 14, 2021
Amount Raised: $5,628,799